Jörgen Mölgaard

649 total citations
14 papers, 459 citations indexed

About

Jörgen Mölgaard is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jörgen Mölgaard has authored 14 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jörgen Mölgaard's work include Lipoproteins and Cardiovascular Health (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Peripheral Artery Disease Management (3 papers). Jörgen Mölgaard is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Peripheral Artery Disease Management (3 papers). Jörgen Mölgaard collaborates with scholars based in Sweden, Australia and Denmark. Jörgen Mölgaard's co-authors include Anders Olsson, Göran Walldius, Ingar Holme, Jan Johansson, Liselotte Schäfer Elinder, Sven Nilsson, Uno Erikson, Claes Lassvik, L. Bergstrand and Karin Hådell and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, The American Journal of Cardiology and Drugs.

In The Last Decade

Jörgen Mölgaard

14 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jörgen Mölgaard Sweden 8 228 162 113 81 67 14 459
Gertrude Dankner Israel 8 191 0.8× 243 1.5× 144 1.3× 84 1.0× 60 0.9× 13 481
Kuniharu Suzumura Japan 10 192 0.8× 98 0.6× 73 0.6× 36 0.4× 41 0.6× 17 403
Pham Thi Tham Vietnam 8 291 1.3× 84 0.5× 87 0.8× 88 1.1× 42 0.6× 20 528
Fred Gey Switzerland 10 211 0.9× 189 1.2× 261 2.3× 60 0.7× 37 0.6× 13 689
Shunichi Toshima Japan 3 128 0.6× 162 1.0× 56 0.5× 62 0.8× 59 0.9× 6 377
Lynn Crosbie United Kingdom 12 90 0.4× 95 0.6× 118 1.0× 54 0.7× 75 1.1× 15 414
Maya S. Gowri United States 10 97 0.4× 81 0.5× 56 0.5× 155 1.9× 44 0.7× 10 450
Paul D. Uhlendorf United States 9 341 1.5× 64 0.4× 64 0.6× 94 1.2× 35 0.5× 10 515
Lucie Boulet Canada 9 285 1.3× 65 0.4× 103 0.9× 107 1.3× 45 0.7× 14 493
Michael Avella United Kingdom 18 362 1.6× 107 0.7× 276 2.4× 186 2.3× 128 1.9× 49 795

Countries citing papers authored by Jörgen Mölgaard

Since Specialization
Citations

This map shows the geographic impact of Jörgen Mölgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörgen Mölgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörgen Mölgaard more than expected).

Fields of papers citing papers by Jörgen Mölgaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörgen Mölgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörgen Mölgaard. The network helps show where Jörgen Mölgaard may publish in the future.

Co-authorship network of co-authors of Jörgen Mölgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Jörgen Mölgaard. A scholar is included among the top collaborators of Jörgen Mölgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörgen Mölgaard. Jörgen Mölgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Mölgaard, Jörgen, et al.. (1999). Efficacy and safety of simvastatin for high-risk hypercholesterolemia. The American Journal of Cardiology. 83(7). 1043–1048. 7 indexed citations
2.
Mölgaard, Jörgen. (1997). Intermittent Claudication : Prevalence and metabolic risk factors. 1 indexed citations
3.
Regnström, Jan, Göran Walldius, Sven Nilsson, et al.. (1996). The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis. Atherosclerosis. 125(2). 217–229. 23 indexed citations
4.
Elinder, Liselotte Schäfer, Karin Hådell, Jan Johansson, et al.. (1995). Probucol Treatment Decreases Serum Concentrations of Diet-Derived Antioxidants. Arteriosclerosis Thrombosis and Vascular Biology. 15(8). 1057–1063. 39 indexed citations
5.
Johansson, Jan, Anders Olsson, L. Bergstrand, et al.. (1995). Lowering of HDL 2b by Probucol Partly Explains the Failure of the Drug to Affect Femoral Atherosclerosis in Subjects With Hypercholesterolemia. Arteriosclerosis Thrombosis and Vascular Biology. 15(8). 1049–1056. 66 indexed citations
6.
Walldius, Göran, Uno Erikson, Anders Olsson, et al.. (1994). The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST). The American Journal of Cardiology. 74(9). 875–883. 180 indexed citations
7.
Mölgaard, Jörgen, Björn L. Lundh, H. von Schenck, & Anders Olsson. (1991). Long-term efficacy and safety of simvastatin alone and in combination therapy in treatment of hypercholesterolaemia. Atherosclerosis. 91. S21–S28. 31 indexed citations
8.
Olsson, Anders & Jörgen Mölgaard. (1990). Relations Between Smoking, Food Intake and Plasma Lipoproteins. Advances in experimental medicine and biology. 273. 237–243. 1 indexed citations
9.
Mölgaard, Jörgen, et al.. (1990). Effect of fish oil treatment on plasma lipoproteins in type III hyperlipoproteinaemia. Atherosclerosis. 81(1). 1–9. 19 indexed citations
10.
Mölgaard, Jörgen & Anders Olsson. (1990). Apolipoprotein Profiles in Randomly Selected Smokers and Matched Controls. Advances in experimental medicine and biology. 273. 259–266. 3 indexed citations
11.
Walldius, Göran, Lars A. Carlson, Uno Erikson, et al.. (1988). Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol quantitative regression Swedish trial (PQRST): A status report. The American Journal of Cardiology. 62(3). B37–B43. 48 indexed citations
12.
Olsson, Anders & Jörgen Mölgaard. (1988). The Future of Pharmacological Therapy for Risk Factor Reduction. Drugs. 36(Supplement 3). 115–120. 1 indexed citations
13.
Mölgaard, Jörgen, H. von Schenck, & Anders Olsson. (1987). Alfalfa seeds lower low density lipoprotein cholesterol and apolipoprotein B concentrations in patients with type II hyperlipoproteinemia. Atherosclerosis. 65(1-2). 173–179. 34 indexed citations
14.
Mölgaard, Jörgen, et al.. (1986). Comparisons between CK-B and other clinical indicators of cardiac contusion following multiple trauma. Scandinavian Journal of Thoracic and Cardiovascular Surgery. 20(1). 93–96. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026